Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Vittoria, Lapadula"'
Autor:
Alfredo Tartarone, Vittoria Lapadula, Concetta Di Micco, Gemma Rossi, Carlotta Ottanelli, Andrea Marini, Roberta Giorgione, Katia Ferrari, Martina Catalano, Luca Voltolini, Enrico Mini, Giandomenico Roviello
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
In the last few years the advent of targeted therapies against oncogenic drivers significantly improved the survival of non small cell lung cancer (NSCLC) patients with a favourable toxicity profile. Therefore, genetic testing, including at least EGF
Externí odkaz:
https://doaj.org/article/f52bbc07371947b09bcce76ad471c3cc
Autor:
Pamela Pizzutilo, Michele Montrone, V. Lamorgese, D. Ricci, Vittoria Lapadula, Sandro Cassiano, D. Bafunno, P. Petrillo, A. Zacheo, Annamaria Catino, Alessandra Di Lauro, Gabriella Del Bene, F. Pesola, A. Mastrandrea, Vito Longo, Domenico Galetta, Niccolò Varesano
Publikováno v:
Journal of Community Health. 46:597-602
Smoking is recognized as the major cause of lung cancer. Healthcare professionals play an important role in lung cancer prevention policies, as they act as a source of guidance for patients and advocates. The following survey evaluated prevalence, kn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cdbeb92931b69be6b9342519e75e0f0
https://doi.org/10.1007/s10900-020-00907-8
https://doi.org/10.1007/s10900-020-00907-8
Autor:
Concetta Di Micco, Giandomenico Roviello, Martina Catalano, G. Rossi, Enrico Mini, Andrea Marini, Roberta Giorgione, Carlotta Ottanelli, Alfredo Tartarone, Katia Ferrari, Luca Voltolini, Vittoria Lapadula
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
In the last few years the advent of targeted therapies against oncogenic drivers significantly improved the survival of non small cell lung cancer (NSCLC) patients with a favourable toxicity profile. Therefore, genetic testing, including at least EGF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1d8012de775b00135fa3693e9f59d8
Autor:
Daniele Rossini, Salvatore Caponnetto, Vittoria Lapadula, Lucilla De Filippis, Gabriella Del Bene, Alessandra Emiliani, Flavia Longo
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Merkel cell carcinoma (MCC) is an extremely rare primary neuroendocrine neoplasm of the skin that shows aggressive behavior and a poor prognosis. We report a case of a 67-year-old male with a Merkel cell carcinoma which initially presented itself as
Externí odkaz:
https://doaj.org/article/4ec5f60910db4d42bd59e304cd4549ad
Autor:
Pamela Pizzutilo, V. Lamorgese, D. Bafunno, Sara Elena Rebuzzi, Vittoria Lapadula, Arsela Prelaj, Vito Longo, Domenico Galetta, Niccolò Varesano, Massimo Bilancia, F. Pesola, P. Petrillo, Annamaria Catino, A. Mastrandrea, Michele Montrone, Donatella Ricci, Gabriella Del Bene, Flavio Cassano
Publikováno v:
Clinical Lung Cancer. 21:365-377.e5
Background Second-line immunotherapy (IO) has shown an overall survival benefit. However, only 18% to 20% of patients with advanced non–small-cell lung cancer (aNSCLC) will respond, with a median progression-free survival (PFS) of 2 to 4 months. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b37277141d26eb40b72575710e1076
https://doi.org/10.1016/j.cllc.2019.11.017
https://doi.org/10.1016/j.cllc.2019.11.017
Autor:
Salvatore Caponnetto, Vittoria Lapadula, Daniele Rossini, Lucilla De Filippis, Alessandra Emiliani, Flavia Longo, Gabriella Del Bene
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2013 (2013)
Case Reports in Oncological Medicine, Vol 2013 (2013)
Merkel cell carcinoma (MCC) is an extremely rare primary neuroendocrine neoplasm of the skin that shows aggressive behavior and a poor prognosis. We report a case of a 67-year-old male with a Merkel cell carcinoma which initially presented itself as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308457da6c0a2f750a26c14716c6f3ba
https://pubmed.ncbi.nlm.nih.gov/24073348
https://pubmed.ncbi.nlm.nih.gov/24073348
Autor:
Rita, De Sanctis, Silvia, Quadrini, Flavia, Longo, Vittoria, Lapadula, Rossella, Restuccia, Ester, Del Signore, Lucilla, De Filippis, Luciano, Stumbo, Bruno, Gori, Vincenzo, Bianco, Iolanda, Speranza, Maria Luisa, Basile, Marisa, Di Seri
Aims and background Capecitabine is the reference treatment for anthracycline-and/or taxane-pretreated metastatic breast cancer (MBC). This study examined its efficacy, tolerability and impact on the quality of life of elderly patients with MBC. Mate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d66ec58c1d09ede2d8233eee2dfd3c27
http://hdl.handle.net/11573/872710
http://hdl.handle.net/11573/872710
Autor:
Silvia Quadrini, Barbara Cimadon, Marisa Di Seri, Vittoria Lapadula, Giovanni Mansueto, Enrico Cortesi, Flavia Longo, Ester Del Signore, Bruno Gori, I. D'Antoni, Teresa Gamucci, L. Stumbo, Roberta Grande, Cristina De Luca, Amelia Altavilla, Rita De Sanctis
The combination of a neurokinin-1 receptor antagonist, dexamethasone, and a 5-HT(3) receptor antagonist is currently the standard antiemetic treatment in patients receiving cisplatin-based high emetogenic chemotherapy (HEC). The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee760f16574092859934cef843c4b43c
http://hdl.handle.net/11573/872721
http://hdl.handle.net/11573/872721
Autor:
Paola Gazzaniga, Lucilla De Filippis, Paolo Baldassarri, Flavia Longo, Daniela Adua, Franco Lafrate, Gabriella Del Bene, Viviana Frantellizzi, Vittoria Lapadula, Luigi Frati
Publikováno v:
Annals of Oncology. 23:iv109
Introduction The aim of this retrospective study is to define the usefulness of an integrated CT software that automatically generates report according to RECIST 1.1 criteria and Choi criteria, evaluating the effects of bevacizumab based chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ab6500f8ec6717b198dfbf45708058d
https://doi.org/10.1016/s0923-7534(20)30205-2
https://doi.org/10.1016/s0923-7534(20)30205-2
Autor:
Paola Gazzaniga, Vittoria Lapadula, Luigi Frati, Paolo Baldassarri, Daniela Adua, Lucilla De Filippis, Flavia Longo, Marco Di Marco, Franco Iafrate, Gabriella Del Bene
Publikováno v:
Journal of Clinical Oncology. 30:e14096-e14096
e14096 Background: The aim of this retrospective study is to define the usefullness of an integrated CT software that automatically generates report according to RECIST 1.1 criteria and Choi criteria, evaluating the effects of bevacizumab based chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5a08205856cc366aa5d24945cf9e117
https://doi.org/10.1200/jco.2012.30.15_suppl.e14096
https://doi.org/10.1200/jco.2012.30.15_suppl.e14096